{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:38:42Z","timestamp":1792147122685,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6794,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1023\/a:1011131700811","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T11:26:45Z","timestamp":1040642805000},"page":"831-834","source":"Crossref","is-referenced-by-count":21,"title":["Clinical and pathological features of posttransplant lymphoproliferative disorders: Influence on survival and response to treatment"],"prefix":"10.1016","volume":"12","author":[{"given":"R.","family":"Hauke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Smir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tarantolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1011131700811_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0955-470X(95)80008-V","article-title":"Analysis of non-Hodgkin\u2019s lymphomas in organ transplant recipients","volume":"9","author":"Opelz","year":"1995","journal-title":"Transplant Rev"},{"key":"10.1023\/A:1011131700811_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.med.46.1.381","article-title":"Classification of Epstein\u2013Barr virus-associated post-transplant lymphoproliferative disease: Implications for understanding their pathogenesis and developing rational treatment strategies s","volume":"46","author":"Hanto","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1023\/A:1011131700811_bb0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0011-3840(88)90011-1","article-title":"The diagnosis and treatment of posttransplant lymphoproliferative disorders","author":"Nalesnik","year":"1988","journal-title":"Curr Probl Surg"},{"key":"10.1023\/A:1011131700811_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10428199209053560","article-title":"Post-transplantation lymphoproliferative disorder","volume":"6","author":"Swinnen","year":"1992","journal-title":"Leuk Lymph"},{"issue":"2","key":"10.1023\/A:1011131700811_bb0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0889-8588(18)30252-1","article-title":"Therapy for transplant-related lymphoproliferative diseases","volume":"7","author":"Benkerrou","year":"1993","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1023\/A:1011131700811_bb0035","series-title":"Medical Uses of Statistics","first-page":"286","article-title":"Statistical analysis of survival data","author":"Lagakos","year":"1992"},{"key":"10.1023\/A:1011131700811_bb0040","series-title":"Neoplastic Hematopathology","first-page":"472","article-title":"Posttransplantation lymphoproliferative disorders","author":"Frizzera","year":"1992"},{"issue":"5, Suppl 1","key":"10.1023\/A:1011131700811_bb0045","first-page":"41","article-title":"Pretransplant assessment of the risk for posttransplant lymphoproliferative disorders","volume":"27","author":"Walker","year":"1995","journal-title":"Transplant Proc"},{"issue":"5, Suppl 1","key":"10.1023\/A:1011131700811_bb0050","first-page":"38","article-title":"Risk factors and the pathogenesis of posttransplant lymphoproliferative disorders","volume":"27","author":"Ho","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1023\/A:1011131700811_bb0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"324","author":"Starzl","year":"1984","journal-title":"Lancet"},{"issue":"7","key":"10.1023\/A:1011131700811_bb0060","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood.V92.7.2294","article-title":"Bcl-6 mutations in posttransplant lymphoproliferative disorders predict response to therapy and clinical outcome","volume":"92","author":"Cesarman","year":"1998","journal-title":"Blood"},{"key":"10.1023\/A:1011131700811_bb0065","first-page":"4a","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder (PTLD): Analysis of prognostic variables and long-term follow-up of 37 patients","volume":"18","author":"Tsai","year":"1999","journal-title":"Proc ASCO"},{"issue":"6","key":"10.1023\/A:1011131700811_bb0070","first-page":"877","article-title":"Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression","volume":"10","author":"Armitage","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1023\/A:1011131700811_bb0075","first-page":"961","article-title":"Clinical characteristics of post-transplant lymphoproliferative disorders","volume":"13","author":"Morrison","year":"1995","journal-title":"Am J Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419479830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419479830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/6\/831\/19479363\/12-6-831.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T06:59:18Z","timestamp":1582181958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419479830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0923753419479830"],"URL":"https:\/\/doi.org\/10.1023\/a:1011131700811","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}